Interleukin-4-producing cells in idiopathic pulmonary fibrosis: An immunohistochemical study

Respirology

Volumn 4, Issue 4, 1999, Pages 383-391

  Ando, Masaru ^a   Miyazaki, Eishi ^a   Fukami, Tetsujiro ^a   Kumamoto, Toshihide ^a   Tsuda, Tomiyasu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Eosinophil; Idiopathic pulmonary fibrosis; Immunohistochemistry; Interleukin 4; Interleukin 4 producing cells; Lymphocyte; Mast cell; Pathogenesis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; HUMAN; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LUNG FIBROSIS; MALE; MAST CELL; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY, NEEDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; LUNG; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0033385544     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.1999.00209.x     Document Type: Article

References (17)

1. Crystal RG, Gadek JE, Ferrans VJ et al. Interstitial lung disease: Current concepts of pathologenesis, staging and therapy. Am. J. Med. 1981; 70: 542-68.
2. Katzenstein AA, Askin FB. Idiopathic interstitial pneumonia/idiopathic pulmonary fibrosis. In: Surgical Pathology of Nonplastic Lung Disease. W.B. Saunders, Philadelphia, 1990; 58-96.
3. Campbell DA, Poulter LW, Janossy G, DuBois RM. Immunological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 1985; 40: 405-11.
4. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine works in the regulation of inflammation and fibrosis in the lung. Chest 1990; 97: 1439-45.
5. Yoshida M, Sakuma J, Hayashi S et al. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin-6, transforming growth factor-β, or platelet-derived growth factor gene. Proc. Natl Acad. Sci. USA 1995; 92: 9570-4.
6. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extra cellular matrix proteins in response to interleukin-4. J. Clin. Invest. 1992; 90: 1479-85.
7. Postlethwaite AE, Seyer JM. Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. J. Clin. Invest. 1991; 87: 2147-52.
8. Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subset of murine lung fibroblasts express membranebound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J. Immunol. 1994; 152: 3606-14.
9. Larner AC, Petricoin EF, Nakagawa Y, Finbloom DS. IL-4 attenuates the transcriptional activation of both IFNγ and IFNγ induced cellular gene expression in monocyte and monocytic cell lines. J. Immunol. 1993; 150: 1944-50.
10. Baecher-Allen CM, Barth RK. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Regional Immunol. 1993; 5: 207-17.
11. Wallace WA, Ramage EA, Lamb D, Howie SE. A type-2 (Th2 like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin. Exp. Immunol. 1995; 101: 436-41.
12. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J. Immunol. 1995; 155: 297-307.
13. Nonaka M, Nonaka R, Woolley K et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils. J. Immunol. 1995; 155: 3234-44.
14. Bradding P, Roberts JA, Britten KM et al. Interleukin-4, -5 and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 1994; 10: 471-80.
15. Barata LT, Ying S, Meng Q et al. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Allergy Clin. Immunol. 1998; 101: 222-30.
16. Watters LC, Schwarz MI, Cherniac RM. Idiopathic pulmonary fibrosis: Pretreatment bronchoalveolar lavage cellular constituents and their response to therapy. Am. Rev. Respir. Dis. 1987; 135: 696-704.
17. Negoescu A, Labat-Moleur F, Lorimier P et al. F(ab) secondary antibodies: A general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence. J. Histochem. Cytochem. 1994; 42: 433-7.